Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors

Nature Immunology

Volumn 5, Issue 5, 2004, Pages 495-502

  Chuang, Tsung Hsien ^a   Ulevitch, Richard J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TRIAD3A; REGULATOR PROTEIN; SMALL INTERFERING RNA; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFECTION CONTROL; INFECTION RESISTANCE; INFLAMMATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION; UBIQUITINATION;

AMINO ACID SEQUENCE; CARRIER PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE GLYCOPROTEINS; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; UBIQUITIN-PROTEIN LIGASES;

EID: 2442643942     PISSN: 15292908     EISSN: None     Source Type: Journal    
DOI: 10.1038/ni1066     Document Type: Article

References (49)

1. Chuang, T.H. & Ulevitch, R.J. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518, 157-161 (2001).
2. Aderem, A. & Ulevitch, R.J. Toll-like receptors in the induction of the innate immune response. Nature 406, 782-787 (2000).
3. Takeda, K., Kaisho, T. & Akira, S. Toll-like receptors. Annu. Rev. Immunol. 21, 335-376 (2003).
4. Sabroe, I., Parker, L.C., Wilson, A.G., Whyte, M.K. & Dower, S.K. Toll-like receptors: their role in allergy and non-allergic inflammatory disease. Clin. Exp. Allergy 32, 984-989 (2002).
5. Zuany-Amorim, C., Hastewell, J. & Walker, C. Toll-like receptors as potential therapeutic targets for multiple diseases. Nat. Rev. Drug Discov. 1, 797-807 (2002).
6. Bochud, P.Y. & Calandra, T. Pathogenesis of sepsis: new concepts and implications for future treatment. BMJ 326, 262-266 (2003).
7. Sweet, M.J. et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression. J. Immunol. 166, 6633-6639 (2001).
8. Wald, D. et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4, 920-927 (2003).
9. Kobayashi, K. et al. IRAK-M is a negative regulator of Toll-like receptor signaling. Cell 110, 191-202 (2002).
10. Nakagawa, R. et al. SOCS-1 participates in negative regulation of LPS responses. Immunity. 17, 677-687 (2002).
11. Pickart, C.M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
12. Glickman, M.H. & Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev. 82, 373-428 (2002).
13. Strous, G.J. & Gent, J. Dimerization, ubiquitylation and endocytosis go together in growth hormone receptor function. FEBS Lett. 529, 102-109 (2002).
14. Dikic, I. & Giordano, S. Negative receptor signalling. Curr. Opin. Cell Biol. 15, 128-135 (2003).
15. Daun, J.M. & Fenton, M.J. Interleukin-1/Toll receptor family members: receptor structure and signal transduction pathways. J. Interferon Cytokine Res. 20, 843-855 (2000).
16. O'Neill, L.A., Fitzgerald, K.A, & Bowie, A.G. The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24, 286-290 (2003).
17. Janssens, S. & Beyaert, R. Functional diversity and regulation of different interleukin-1 receptor-associated kinase (IRAK) family members. Mol. Cell 11, 293-302 (2003).
18. Barton, G.M. & Medzhitov, R. Linking Toll-like receptors to IFN-α/β expression. Nat. Immunol. 4, 432-433 (2003).
19. van der Reijden, B.A., Erpelinck-Verschueren, C.A., Lowenberg, B. & Jansen, J. H. TRIADs: a new class of proteins with a novel cysteine-rich signature. Protein Sci. 8, 1557-1561 (1999).
20. Chen, D., Li, X., Zhai, Z. & Shu, H.B. A novel zinc finger protein interacts with receptor-interacting protein (RIP) and inhibits tumor necrosis factor (TNF)- and IL1-induced NF-κB activation. J. Biol. Chem. 277, 15985-15991 (2002).
21. Shimura, H. et al. Ubiquitination of a new form of α-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269 (2001).
22. Chung, K.K. et al. Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat. Med. 7, 1144-1150 (2001).
23. Zhang, Y. et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl. Acad. Sci. USA 97, 13354-13359 (2000).
24. Niwa, J. et al. Dorfin ubiquitylates mutant SOD1 and prevents mutant SOD1-mediated neurotoxicity. J. Biol. Chem. 277, 36793-36798 (2002).
25. Moynihan, T.P. et al. The ubiquitin-conjugating enzymes UbcH7 and UbcH8 interact with RING finger/IBR motif-containing domains of HHARI and H7-AP1. J. Biol. Chem. 274, 30963-30968 (1999).
26. Martinez-Noel, G., Niedenthal, R., Tamura, T. & Harbers, K. A family of structurally related RING finger proteins interacts specifically with the ubiquitin-conjugating enzyme UbcM4. FEBS Lett. 454, 257-261 (1999).
27. Lee, D.H. & Goldberg, A.L. Proteasome inhibitors: valuable new tools for cell biologists. Trends Cell Biol. 8, 397-403 (1998).
28. Gropper, R. et al. The ubiquitin-activating enzyme, E1, is required for stress-induced lysosomal degradation of cellular proteins. J. Biol. Chem. 266, 3602-3610 (1991).
29. Barrett, A.J. et al. L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L. Biochem. J. 201, 189-198 (1982).
30. Shimazu, R. et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189, 1777-1782 (1999).
31. da Silva, C.J., Soldau, K., Christen, U., Tobias, P.S. & Ulevitch, R.J. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J. Biol. Chem. 276, 21129-21135 (2001).
32. Pugin, J., Ulevitch, R.J. & Tobias, P.S. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation. J. Exp. Med. 178, 2193-2200 (1993).
33. Sellati, T.J., Abrescia, L.D., Radolf, J.D. & Furie, M.B. Outer surface lipoproteins of Borrelia burgdorferi activate vascular endothelium in vitro. Infect. Immun. 64, 3180-3187 (1996).
34. Macfarlane, D.E. & Manzel, L. Antagonism of immunostimulatory CpG-oligodeoxynucleotides by quinacrine, chloroquine, and structurally related compounds. J. Immunol. 160, 1122-1131 (1998).
35. Hoebe, K. et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trif-independent pathways. Nat. Immunol. 4, 1223-1229 (2003).
36. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 (1998).
37. Aguilera, M., Oliveros, M., Martinez-Padron, M., Barbas, J.A. & Ferrus, A. Ariadne-1: a vital Drosophila gene is required in development and defines a new conserved family of ring-finger proteins. Genetics 155, 1231-1244 (2000).
38. Sakata, E. et al. Parkin binds the Rpn10 subunit of 26S proteasomes through its ubiquitin-like domain. EMBO Rep. 4, 301-306 (2003).
39. Yamin, T.T. & Miller, D.K. The interleukin-1 receptor-associated kinase is degraded by proteasomes following its phosphorylation. J. Biol. Chem. 272, 21540-21547 (1997).
40. Li, L., Cousart, S., Hu, J. & McCall, C.E. Characterization of interleukin-1 receptor-associated kinase in normal and endotoxin-tolerant cells. J. Biol. Chem. 275, 23340-23345 (2000).
41. Bosisio, D. et al. Stimulation of toll-like receptor 4 expression in human mononuclear phagocytes by interferon-γ: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99, 3427-3431 (2002).
42. Marsik, C. et al. Endotoxaemia modulates Toll-like receptors on leucocytes in humans. Br. J. Haematol. 121, 653-656 (2003).
43. Girnita, L., Girnita, A. & Larsson, O. Mdm2-dependent ubiquitination and degradation of the insulin-like growth factor 1 receptor. Proc. Natl. Acad. Sci. USA 100, 8247-8252 (2003).
44. 2-adrenergic receptor and β-arrestin. Science 294, 1307-1313 (2001).
45. Cohen, B.D., Bariteau, J.T., Magenis, L.M. & Dias, J.A. Regulation of follitropin receptor cell surface residency by the ubiquitin-proteasome pathway. Endocrinology 144, 4393-4402 (2003).
46. Yamakami, M., Yoshimori, T. & Yokosawa, H. Tom1, a VHS domain-containing protein, interacts with Tollip, ubiquitin, and clathrin. J. Biol. Chem. 278, 52865-52872 (2003).
47. Zhang, G. & Ghosh, S. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 277, 7059-7065 (2002).
48. Chuang, T.H., Lee, J., Kline, L., Mathison, J.C. & Ulevitch, R.J. Toll-like receptor 9 mediates CpG-DNA signaling. J. Leukoc. Biol. 71, 538-544 (2002).
49. Chuang, T.H. & Ulevitch, R.J. Cloning and characterization of a sub-family of human toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11, 372-378 (2000).